16.05.2005 15:31:00
|
Astro-Med to Present at Inaugural Chinese Association Against Epilepsy
Business Editors/Health/Medical Writers
WEST WARWICK, R.I.--(BUSINESS WIRE)--May 16, 2005--Grass-Telefactor, a Product Group of Astro-Med, Inc. (NASDAQ:ALOT) has been selected to give a technical presentation at the first ever Chinese Association Against Epilepsy (CAAE) conference in Beijing, People's Republic of China, which will be held on June 24-25, 2005.
The newly formed CAAE is a national, non-governmental, non-profit organization composed of epileptologists, other professionals and people who are interested and/or working at epilepsy treatment, prevention, research and care; including people with epilepsy and their family members and local epilepsy related organizations.
During the past two decades, great effort has been made to form a national association against epilepsy in China. Epileptologists have been organized in groups in many provinces and cities under the leadership of local medical associations. The Beijing Association Against Epilepsy was formed and approved by local government in 1991. In 2002, efforts were expedited and the application of China Association Against Epilepsy (CAAE) was approved by the Ministry of Health of China in early 2004.
The Official Inauguration of the CAAE will take place on June 24, 2005 at the Great Hall of the People in Beijing with professional conferences to follow on the 25th. CAAE already has more than 1700 registered individual members and is expecting several hundred attendees from all over China to participate in the conference.
Commenting on inclusion in the inaugural event, Eric Menke, International Sales Manager for Astro-Med said: "Grass-Telefactor is very honored to be the only non-Chinese company invited to present at this prestigious event. China's potential market presents a great opportunity for any U.S. company and it is clear that Grass-Telefactor is already held in high regard among epileptologists and neurologists in China."
The Grass-Telefactor Product Group of Astro-Med designs, manufactures, and sells a broad range of advanced EEG and PSG (sleep monitoring) systems, Long Term Epilepsy systems, as well as a broad range of products for neurophysiological research employed around the world in a wide range of clinical and research applications.
Safe Harbor Statement
This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med's FY2005 annual report and its annual and quarterly filings with the Securities and Exchange Commission.
--30--NM/ny*
CONTACT: Astro-Med, Inc. Everett V. Pizzuti, 401-828-4000
KEYWORD: RHODE ISLAND CHINA INTERNATIONAL ASIA PACIFIC INDUSTRY KEYWORD: MEDICAL DEVICES TRADESHOW PRODUCT SOURCE: Astro-Med, Inc.
Copyright Business Wire 2005
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Astro-Med Inc.mehr Nachrichten
19.12.24 |
NASDAQ Composite Index-Titel Astro-Med-Aktie: So viel Verlust hätte ein Astro-Med-Investment von vor einem Jahr eingefahren (finanzen.at) | |
18.12.24 |
Schwache Performance in New York: NASDAQ Composite fällt zum Handelsstart (finanzen.at) | |
13.12.24 |
Optimismus in New York: NASDAQ Composite letztendlich mit Zuschlägen (finanzen.at) | |
13.12.24 |
NASDAQ-Handel: NASDAQ Composite zum Start des Freitagshandels in der Gewinnzone (finanzen.at) | |
12.12.24 |
Angespannte Stimmung in New York: NASDAQ Composite schwächelt (finanzen.at) | |
12.12.24 |
Schwacher Wochentag in New York: NASDAQ Composite leichter (finanzen.at) | |
12.12.24 |
Schwacher Handel in New York: NASDAQ Composite verbucht zum Start Abschläge (finanzen.at) | |
12.12.24 |
NASDAQ Composite Index-Wert Astro-Med-Aktie: So viel Gewinn hätte ein Investment in Astro-Med von vor 10 Jahren eingebracht (finanzen.at) |
Analysen zu Astro-Med Inc.mehr Analysen
Aktien in diesem Artikel
Astro-Med Inc. | 12,50 | -3,85% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 572,60 | 1,03% |